amiodarone has been researched along with Parkinsonian Disorders in 2 studies
Amiodarone: An antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance.
amiodarone : A member of the class of 1-benzofurans that is 1-benzofuran substituted by a butyl group at position 2 and a 4-[2-(diethylamino)ethoxy]-3,5-diiodobenzoyl group at position 3. It is a cardiovascular drug used for the treatment of cardiac dysrhythmias.
Parkinsonian Disorders: A group of disorders which feature impaired motor control characterized by bradykinesia, MUSCLE RIGIDITY; TREMOR; and postural instability. Parkinsonian diseases are generally divided into primary parkinsonism (see PARKINSON DISEASE), secondary parkinsonism (see PARKINSON DISEASE, SECONDARY) and inherited forms. These conditions are associated with dysfunction of dopaminergic or closely related motor integration neuronal pathways in the BASAL GANGLIA.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Some case reports have described parkinsonism with amiodarone." | 1.62 | Amiodarone and Parkinsonism: a pharmacovigilance study. ( Durrieu, G; Montastruc, JL, 2021) |
| "Twenty-two patients with Parkinsonism during amiodarone therapy were evaluated by clinical neurological examination and FP-CIT SPECT." | 1.36 | FP-CIT SPECT in clinically inconclusive Parkinsonian syndrome during amiodarone treatment: a study with follow-up. ( Dethy, S; Hambÿe, AS; Vervaet, A, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Montastruc, JL | 1 |
| Durrieu, G | 1 |
| Hambÿe, AS | 1 |
| Vervaet, A | 1 |
| Dethy, S | 1 |
2 other studies available for amiodarone and Parkinsonian Disorders
| Article | Year |
|---|---|
Amiodarone and Parkinsonism: a pharmacovigilance study.
Topics: Adverse Drug Reaction Reporting Systems; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents | 2021 |
FP-CIT SPECT in clinically inconclusive Parkinsonian syndrome during amiodarone treatment: a study with follow-up.
Topics: Aged; Amiodarone; Diagnosis, Differential; Female; Follow-Up Studies; Humans; Male; Parkinson Diseas | 2010 |